Day Twentyfive


Got apples and grapes today, for the first time during the lockdown. That and noticing the cobbler in his corner gave me a fleeting sense of normalcy. Many conditional relaxations have been announced for the rural areas, starting 20th April. E-commerce will be allowed for non-essential goods too. Plumbers, electricians, carpenters and similar self-employed people will be allowed to work. But cases continue to rise in Mumbai. And the morbidity rate of Mumbai is the highest. The explanation, following an audit of the deaths, is that people are getting admitted very late. Normalcy appears far away for Mumbai. Hydroxychloroquine is being given as a prophylactic to the high risk people in Dharavi. 

HCQ figured prominently in today’s Social Distance of The Atlantic, my go to podcast every morning. Katherine Wells and James Hamblin enlighten and entertain. I send them an appreciative tweet after listening to today’s podcast. The drug is polarising USA, with Trump and his cronies going on a propaganda overdrive. There is this brilliant insight in the podcast: I remember one time I had a conversation with someone who grew up in China, and we were talking about the misinformation in Chinese media and state-controlled media and things like that. And I was like, “Oh, that seems so disorienting.” And I remember she said, “Well, in China, we just know not to trust it. But in the U.S., you still actually believe the things you hear.”

The redoubtable Scientific American has a lowdown on the current status of the various treatment approaches to COVID-19
Chloroquine and Hydrochloroquine
Remdesivir
Ritonavir and Lopinavir
Plasma Therapy


53 severely ill patients were given Remdesivir as part of a “compassionate use” program; after receiving the drug, more than half the patients on ventilators were taken off, and 47% of the patients were discharged from the hospital. Gilead is conducting multiple trials for Remdesivir and will release more data in May,

Kerala has kicked off the first convalescent plasma therapy in the country. The plasma obtained from the blood of a recovered COVID19 patient is infused to a critically ill patient to confer a possible immunity. It is a measure of desperation and ICMR hasinvited proposals to launch clinical trials in the next 2 weeks. 

Meanwhile Vaccine continues to the best hope in the long run. Many vaccine candidates are in the race now. Current edition of Babbage has an excellent story on vaccine.

Why a coronavirus vaccine could take way longer than a year


And there are reports that China used traditional Chinese medicine in 90% of its COVID19 patients with astounding success. But much of it is myth and not verified scientifically. China wants to hold it up with pride as part of its culture and also export it to other countries. 

Comments

Popular posts from this blog

World's First Vaccine?

Day Six

Day Eightythree